Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Merck
Fuji
Colorcon
Covington
Queensland Health
UBS
AstraZeneca
Johnson and Johnson
Baxter

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,093,423

« Back to Dashboard

Summary for Patent: 8,093,423
Title:Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Abstract: The present invention discloses a pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A manufacturing and quality control process for making a pharmaceutical-grade ferric citrate that consistently complies with the established Manufacture Release Specification is also disclosed. The pharmaceutical-grade ferric organic compounds are suitable for treating disorders characterized by elevated serum phosphate levels.
Inventor(s): Chan; Keith (Rockville, MD), Town; Winston (Hong Kong, HK)
Assignee: GloboAsia, LLC (Rockville, MD)
Application Number:12/064,058
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 8,093,423

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up CONTROL OF SERUM PHOSPHOROUS LEVELS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,093,423

PCT Information
PCT FiledAugust 18, 2006PCT Application Number:PCT/US2006/032385
PCT Publication Date:February 22, 2007PCT Publication Number: WO2007/022435

Non-Orange Book US Patents Family Members for Patent 8,093,423

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,767,851 Ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
8,609,896 Ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
9,050,316 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
8,754,257 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
8,846,976 Ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
9,328,133 Ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
8,901,349 Ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
8,754,258 Ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
8,299,298 Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same ➤ Sign Up
9,757,416 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,093,423

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004213819 ➤ Sign Up
Australia 2006279333 ➤ Sign Up
Australia 2007210090 ➤ Sign Up
Australia 2007210096 ➤ Sign Up
Canada 2516471 ➤ Sign Up
Canada 2619591 ➤ Sign Up
Canada 2640763 ➤ Sign Up
Canada 2640974 ➤ Sign Up
China 100386336 ➤ Sign Up
China 101253186 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Julphar
Deloitte
Citi
Daiichi Sankyo
Medtronic
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot